Shiaw-lin (billy) Wu

Biography

Dr. Wu is Chief Scientific Officer of BioAnalytix. Dr. Wu developed his expertise in advanced analytics and biologic drug development with Genentech, where he spent nine years in areas of protein chemistry and advanced analytical methods for complex characterizations of biologic pharmaceuticals. After that, he further developed his analytic expertise with ThermoFisher Scientific where he worked in developing methods and applications of hybrid mass spectrometry in proteomics. During his time at the Barnett Institute, Dr. Wu focused on various advanced analytical techniques and methods for complex protein analysis and biologic drug characterization, including ETD for complicated disulfide characterization, LC-MS for biosimilar comparison mapping, and protein PK/PD characterization analyses using unique sample preparation techniques combined with hybrid mass spectrometry. Dr. Wu’s primary focus has been in applying these advanced analytical approaches in biologic drug development and regulatory strategies with multiple pharmaceutical and biotechnology companies in the US and abroad. He has published more than 70 scientific papers in these areas.

Research Interest

biologic pharmaceuticals